Reports for JAMP PHARMA CORPORATION
Company Name
JAMP PHARMA CORPORATION
Totals |
||
Shortage reports |
526 |
|
| Actual shortage: | 140 (27%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 1 (0%) | |
| Resolved: | 385 (73%) | |
Discontinuation Reports |
14 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 14 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
125 (23%) |
|
Overdue reports |
81 (58%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-EZETIMIBE | 10MG | TABLET | Resolved | 2023-05-11 | 2023-08-09 | 192236 |
| CETIRIZINE EXTRA STRENGTH | 10MG | TABLET CAPSULE | Resolved | 2023-10-18 | 2024-01-04 | 207328 |
| JAMP RABEPRAZOLE | 10MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2023-11-29 | 2024-03-19 | 211804 |
| JAMP-FLUOXETINE | 10MG | CAPSULE | Actual shortage | 2024-02-07 | 2024-03-19 | 218706 |
| JAMP ENALAPRIL | 10MG | TABLET | Resolved | 2024-02-08 | 2024-03-19 | 218852 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG 150MG | TABLET | Resolved | 2017-03-27 | 2017-09-27 | 4437 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG 150MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96180 |
| JAMP CANDESARTAN-HCT | 12.5MG 16MG | TABLET | Actual shortage | 2024-02-07 | 2024-04-17 | 218700 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG 300MG | TABLET | Resolved | 2017-03-27 | 2017-09-27 | 4430 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG 300MG | TABLET | Resolved | 2017-03-27 | 2017-09-27 | 4441 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG 300MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96183 |
| JAMP-IRBESARTAN AND HYDROCHLOROTHIAZIDE | 12.5MG 300MG | TABLET | Actual shortage | 2019-10-11 | 2021-04-05 | 96192 |
| JAMP CANDESARTAN-HCT | 12.5MG 32MG | TABLET | Resolved | 2021-11-24 | 2021-12-21 | 149815 |
| JAMP CANDESARTAN-HCT | 12.5MG 32MG | TABLET | Resolved | 2021-11-24 | 2021-12-21 | 149818 |
| JAMP CANDESARTAN-HCT | 12.5MG 32MG | TABLET | Actual shortage | 2023-11-28 | 2024-04-17 | 211768 |
| JAMP CANDESARTAN-HCT | 12.5MG 32MG | TABLET | Actual shortage | 2023-11-28 | 2024-04-17 | 211771 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Resolved | 2017-09-29 | 2018-05-19 | 23901 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Resolved | 2017-09-29 | 2018-05-19 | 23908 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-10-07 | 2022-09-09 | 95707 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Resolved | 2019-10-07 | 2022-09-09 | 95713 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113293 |
| JAMP-ALPRAZOLAM | 0.25MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113296 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113299 |
| JAMP-ALPRAZOLAM | 0.5MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113302 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168995 |
| JAMP-RIZATRIPTAN IR | 10MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168998 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168987 |
| JAMP-LOSARTAN HCTZ | 12.5MG 50MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168990 |
| JAMP-ALPRAZOLAM | 1MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113305 |
| JAMP-SILDENAFIL | 25.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169003 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168981 |
| JAMP-LOSARTAN HCTZ | 25MG 100MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 168984 |
| JAMP-ALPRAZOLAM | 2MG | TABLET | Discontinued | 2020-04-27 | 2020-04-27 | 113308 |
| JAMP-SILDENAFIL | 50.0MG | TABLET | Discontinued | 2022-09-09 | 2022-09-09 | 169006 |
Showing 1 to 14 of 14